Foghorn Therapeutics (FHTX) Market Capitalization (2020 - 2026)
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Market Capitalization (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Foghorn Therapeutics | 347.14 Mn | 279.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 286.53 Mn |
| Mar 31, 2026 | 280.64 Mn |
| Dec 31, 2025 | 305.95 Mn |
| Sep 30, 2025 | 276.49 Mn |
| Jun 30, 2025 | 262.28 Mn |
| Mar 31, 2025 | 203.38 Mn |
| Dec 31, 2024 | 262.40 Mn |
| Sep 30, 2024 | 517.57 Mn |
| Jun 30, 2024 | 318.14 Mn |
| Mar 31, 2024 | 285.75 Mn |
| Dec 31, 2023 | 272.72 Mn |
| Sep 30, 2023 | 211.09 Mn |
| Jun 30, 2023 | 294.64 Mn |
| Mar 31, 2023 | 259.31 Mn |
| Dec 31, 2022 | 266.71 Mn |
| Sep 30, 2022 | 358.64 Mn |
| Jun 30, 2022 | 566.14 Mn |
| Mar 31, 2022 | 630.97 Mn |
| Dec 31, 2021 | 944.52 Mn |
| Sep 30, 2021 | 516.03 Mn |